Aurobindo Pharma Limited (AUROPHARMA)
ISIN: - Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
517.05
-3.65(-0.7%)

Aurobindo Pharma Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients, generic pharmaceuticals, and related services in India. The company primarily offers oral solids, injectables, and over-the-counter drugs, as well as active pharmaceutical ingredients and finished dosage forms for cardiovascular, central nervous system, gastroenterology, anti-allergies, anti-diabetics, anti-retroviral, antibiotics, dermatology, respiratory, and oncology. It is also involved in the development of a product pipeline in biosimilar and vaccine segments; and custom research and manufacturing activities for the bio-tech and pharmaceutical community. In addition, the company develops and manufactures peptides, as well as biocatalysts for use in the pharmaceutical and chemical industries. Further, it is developing biosimilar, inhalers, transdermal patches, vaccines, topicals, and depot injections. The company also exports its products. It serves multinational companies. The company has an agreement with COVAXX to develop and commercialize COVID-19 Vaccine for India and UNICEF. Aurobindo Pharma Limited was incorporated in 1986 and is headquartered in Hyderabad, India.

Pricing Updates

TODAY'S HIGH

529.5

TODAY'S LOW

515

52 WEEK HIGH

751.9

52 WEEK LOW

503.45

Major Holders

% of Shares Held by
All Insider

50.66%

% of Shares Held by
Institutions

25.58%

% of Float Held by
Institutions

51.83%

Number of Institutions
Holding Shares

159

Company Overview

MARKET CAP

30295.97 Cr.

ETERPRISE VALUE

29050.68 Cr.

NO. OF SHARES

58.59 Cr.

BOOK VALUE

419.429

DIV. YIELD

4.5%

DEBT

2851.27 Cr.

GROSS PROFIT

13005.61 Cr.

CASH

4566.29 Cr.

REVENUE

23989.42 Cr.

REVENUE/SHARE

409.38

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments-410.98 Cr.-494.52 Cr.-187.68 Cr.-72.07 Cr.
Change To Liabilities110.66 Cr.126.42 Cr.295.87 Cr.-499.28 Cr.
Total cashflows from Investing Activities-3211.56 Cr.598.69 Cr.-1567.64 Cr.-2902.59 Cr.
Net Borrowings-2687.07 Cr.-1082.44 Cr.-1632.36 Cr.2230.39 Cr.
Total Cash from Financing Activities-2969.27 Cr.-1364.81 Cr.-1947.18 Cr.1919.06 Cr.
Other Liabilities360.47 Cr.-315.50 Cr.1195.14 Cr.-81.57 Cr.
Total Assets0019 Lakhs6 Lakhs
Net Income2648.15 Cr.5334.84 Cr.2845.14 Cr.2364.73 Cr.
Change in Cash-1167.40 Cr.2583.09 Cr.871.24 Cr.665.64 Cr.
Effect of Exchange Rate20 Lakhs-2.12 Cr.4.78 Cr.-1.80 Cr.
Total Cash from Operating Activities5016.48 Cr.3328.92 Cr.4381.28 Cr.1650.97 Cr.
Depreciation1126.52 Cr.1055.39 Cr.963.21 Cr.667.72 Cr.
Other Cashflows from Investing Activities100.19 Cr.19.15 Cr.21.78 Cr.26.28 Cr.
Dividends Paid-263.70 Cr.-234.31 Cr.-175.61 Cr.-146.02 Cr.
Change to Inventory1497.52 Cr.-1593.58 Cr.-526.98 Cr.-886.04 Cr.
Change to Account Receivables-410.84 Cr.715.88 Cr.-656.12 Cr.-17.61 Cr.
Other Cashflows from Financing Activities-18.50 Cr.-48.06 Cr.-139.40 Cr.-165.37 Cr.
Change to Net Income-316 Cr.-1994.53 Cr.261.52 Cr.102.79 Cr.
Capital Expenditures-2052.91 Cr.-1437.94 Cr.-1382.75 Cr.-1425.68 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax3372.74 Cr.7343.59 Cr.3743.04 Cr.3091.35 Cr.
Minority Interest-1.93 Cr.-88 Lakhs14 Lakhs1.59 Cr.
Net Income3260.25 Cr.4453.57 Cr.3940.09 Cr.3311.83 Cr.
Selling General Administrative3450.92 Cr.3657.56 Cr.3333.29 Cr.2738.91 Cr.
Gross Profit13315.21 Cr.14584.85 Cr.13069.93 Cr.10595.85 Cr.
Ebit3260.25 Cr.4453.57 Cr.3940.09 Cr.3311.83 Cr.
Operating Income3260.25 Cr.4453.57 Cr.3940.09 Cr.3311.83 Cr.
Other Operating Expenses5477.52 Cr.5418.33 Cr.4829.84 Cr.3877.16 Cr.
Interest Expense-48.64 Cr.-59.57 Cr.-287 Cr.-250.72 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense725.63 Cr.2009.77 Cr.899.35 Cr.726.85 Cr.
Total Revenue23455.49 Cr.24774.62 Cr.23098.51 Cr.19563.55 Cr.
Total Operating Expenses20195.24 Cr.20321.05 Cr.19158.42 Cr.16251.72 Cr.
Cost of Revenue10140.28 Cr.10189.77 Cr.10028.58 Cr.8967.70 Cr.
Total Other Income Expense Net112.49 Cr.2890.02 Cr.-197.05 Cr.-220.48 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.2647.11 Cr.5333.82 Cr.2843.69 Cr.2364.50 Cr.
Net Income Applicable to Common Shares2648.15 Cr.5334.83 Cr.2845.13 Cr.2364.73 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets3137.87 Cr.2554.60 Cr.2342.02 Cr.2271.45 Cr.
Capital Surplus0417.89 Cr.417.89 Cr.417.64 Cr.
Total Liabilities9347.67 Cr.11925 Cr.12102.93 Cr.12561.99 Cr.
Stock Holder Equity24575.98 Cr.21929.87 Cr.16824.67 Cr.13890.78 Cr.
Minority Interest-1.93 Cr.-88 Lakhs14 Lakhs1.59 Cr.
Other Liabilities2998.92 Cr.1316.10 Cr.1174.90 Cr.794.99 Cr.
Total Assets33921.72 Cr.33853.99 Cr.28927.74 Cr.26454.36 Cr.
Common Stock58.59 Cr.58.59 Cr.58.59 Cr.58.59 Cr.
Retained Earnings020949.92 Cr.15855.56 Cr.13229.31 Cr.
Other Liabilities623.87 Cr.825.26 Cr.453.88 Cr.361.47 Cr.
Good Will475.42 Cr.428.90 Cr.915.94 Cr.832.51 Cr.
Treasury Stock24517.39 Cr.503.47 Cr.492.63 Cr.185.24 Cr.
Other Assets901.44 Cr.1300.26 Cr.585.98 Cr.622.32 Cr.
Cash4190.01 Cr.5373.47 Cr.2763.71 Cr.1883.70 Cr.
Current Liabilities8155.98 Cr.10665.15 Cr.11384.64 Cr.12020.57 Cr.
Long Term Asset Charges288.59 Cr.452.68 Cr.163.20 Cr.183.29 Cr.
Short Long Term Debt00139.67 Cr.213.60 Cr.
Other Stockholder Equity24517.39 Cr.503.47 Cr.492.63 Cr.185.24 Cr.
Property Plant Equipment10666 Cr.9315.51 Cr.8116.61 Cr.7035.59 Cr.
Total Cur. Assets18122.69 Cr.19823.51 Cr.16412.51 Cr.15332.30 Cr.
Long Term Investments618.30 Cr.431.21 Cr.554.68 Cr.360.19 Cr.
Net Tangible Assets20962.69 Cr.18946.37 Cr.13566.71 Cr.10786.82 Cr.
Short Term Investments378.85 Cr.257.98 Cr.75.91 Cr.71.11 Cr.
Net Receivables4024.97 Cr.4015.46 Cr.4818.19 Cr.5337.42 Cr.
Long Term Debt249.21 Cr.168.40 Cr.0131.07 Cr.
Inventory7553.85 Cr.9026.57 Cr.7699.87 Cr.7245.60 Cr.
Accounts Payable2703.05 Cr.2794.68 Cr.2576.06 Cr.2552.18 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account